V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001516 | 230009116 | 1.68 | 73 | null | 2018-03-14 | 2018-03-17 | NIVOLUMAB | null | null | PACLITAXEL | 100349291 |
| 230001520 | 230009117 | 1.59 | 61 | Palliative (P) | null | 2020-06-06 | Bevacizumab+Carbo+Pacliaxel | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100488711 |
| 230001521 | 230009118 | 1.45 | 70.3 | null | 2016-04-22 | 2017-03-16 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101062463 |
| 230001522 | 230009119 | 1.65 | 122 | Palliative (P) | 2018-01-25 | 2018-05-01 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100092317 |
| 230001535 | 230009123 | 1.55 | 70.1 | null | 2019-12-02 | 2019-12-03 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100476314 |
| 230001540 | 230009125 | 1.59 | 64.6 | null | null | 2016-11-05 | ICON8B TRIAL | 02 | null | FLUOROURACIL | 100852176 |
| 230001543 | 230009126 | null | null | Adjuvant (A) | 2020-04-29 | 2020-05-07 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | PEMBROLIZUMAB | 100021021 |
| 230001547 | 230009127 | 1.65 | 63.5 | null | 2019-01-09 | 2019-06-04 | Bevacizumab+Carbo+Pacliaxel | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100080866 |
| 230001560 | 230009132 | 1.62 | 94.95 | null | null | 2018-08-11 | null | 01 | null | OLAPARIB | 101412796 |
| 230001561 | 230009133 | 1.61 | 45.2 | null | 2020-07-31 | 2020-09-18 | null | 01 | null | IPILIMUMAB + NIVOLUMAB | 101444813 |
| 230001564 | 230009134 | null | null | null | null | 2020-02-26 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | PEMBROLIZUMAB | 100295757 |
| 230001565 | 230009135 | 1.65 | 93.8 | Palliative (P) | null | 2019-05-23 | null | 02 | N | PEMBROLIZUMAB | 101673037 |
| 230001567 | 230009136 | 1.54 | 62.5 | null | 2021-02-20 | 2021-02-28 | PACLITAXEL | 02 | null | PACLITAXEL | 101215167 |
| 230001568 | 230009137 | 1.53 | 82 | Palliative (P) | null | 2016-12-10 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100179612 |
| 230001570 | 230009138 | null | null | Neo-adjuvant (N) | 2021-07-09 | 2021-07-10 | null | null | N | IPILIMUMAB + NIVOLUMAB | 100032662 |
| 230001571 | 230009139 | 1.56 | 86.3 | null | 2022-02-03 | 2022-02-09 | null | 02 | null | PEMBROLIZUMAB | 100538691 |
| 230001572 | 230009140 | 1.65 | 89.3 | Palliative (P) | null | 2021-08-19 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101648060 |
| 230001581 | 230009142 | 1.52 | 74 | null | 2020-06-12 | 2020-06-19 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100520668 |
| 230001584 | 230009144 | 1.53 | 89.5 | Neo-adjuvant (N) | 2020-01-04 | 2020-01-16 | null | 02 | N | PEMBROLIZUMAB | 101728499 |
| 230001586 | 230009146 | 1.6 | 56 | null | 2018-02-18 | 2018-02-24 | null | null | null | BEVACIZUMAB | 101071520 |
| 230001588 | 230009148 | null | null | null | 2019-07-24 | 2019-07-24 | Niraparib | 02 | null | NIRAPARIB | 100263283 |
| 230001593 | 230009151 | 1.57 | null | Curative (C) | 2021-06-28 | 2021-07-12 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101052169 |
| 230001595 | 230009152 | 1.53 | 63.2 | Palliative (P) | null | 2020-02-11 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100293287 |
| 230001597 | 230009153 | null | null | null | null | 2020-03-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101314662 |
| 230001599 | 230009155 | 1.7 | 73.3 | null | 2020-02-23 | 2020-03-07 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101790990 |
| 230001611 | 230009157 | 1.8 | 101 | null | null | 2020-10-16 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100754810 |
| 230001613 | 230009158 | null | null | null | 2018-11-26 | 2019-03-05 | Bevacizumab | 02 | null | BEVACIZUMAB | 101672262 |
| 230001616 | 230009159 | 1.59 | 86.2 | null | 2020-05-13 | 2020-06-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100505611 |
| 230001620 | 230009161 | 1.57 | 59.5 | null | 2021-01-09 | 2021-07-14 | Olaparib | 02 | N | OLAPARIB | 100388675 |
| 230001632 | 230009164 | 1.66 | 93.5 | null | 2019-06-28 | 2019-08-07 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100133467 |
| 230001634 | 230009165 | null | null | null | 2018-10-06 | 2018-12-05 | Etoposide oral | 02 | null | CISPLATIN | 101508613 |
| 230001638 | 230009167 | null | null | null | 2021-02-27 | 2021-02-27 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101616533 |
| 230001645 | 230009168 | 1.44 | 84 | Palliative (P) | 2021-09-11 | 2021-09-21 | null | null | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101842029 |
| 230001654 | 230009172 | null | null | Curative (C) | 2020-10-14 | 2021-04-15 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100223869 |
| 230001662 | 230009173 | null | null | Curative (C) | null | 2017-02-15 | null | 02 | N | CISPLATIN | 100739333 |
| 230001668 | 230009174 | 1.59 | 86.2 | Neo-adjuvant (N) | 2021-12-11 | 2022-01-15 | PEMBROLIZUMAB | 02 | N | CISPLATIN + ETOPOSIDE | 101809469 |
| 230001677 | 230009176 | null | null | Neo-adjuvant (N) | 2019-08-14 | 2019-08-29 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101013375 |
| 230001680 | 230009177 | 1.57 | 60.5 | null | null | 2021-05-11 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101385244 |
| 230001689 | 230009180 | 1.61 | 93.8 | null | 2021-10-31 | 2022-04-03 | null | null | null | BEVACIZUMAB + CARBO + PACLITAXEL | 101682187 |
| 230001690 | 230009181 | 1.6 | 77 | Palliative (P) | 2019-06-25 | 2019-07-02 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100021121 |
| 230001691 | 230009182 | null | null | Palliative (P) | null | 2019-08-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101268722 |
| 230001697 | 230009184 | null | null | null | 2018-08-14 | 2018-08-16 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100546781 |
| 230001698 | 230009185 | 1.61 | 56.2 | null | null | 2020-01-15 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101756307 |
| 230001701 | 230009186 | null | null | null | null | 2018-07-05 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100154763 |
| 230001706 | 230009188 | 1.71 | 66.4 | Palliative (P) | 2016-10-06 | 2017-04-18 | null | null | null | PEMBROLIZUMAB | 100983724 |
| 230001712 | 230009189 | 1.62 | 121.6 | null | null | 2019-11-01 | null | 2 | null | PACLITAXEL | 100945253 |
| 230001716 | 230009191 | 1.51 | 110 | Palliative (P) | null | 2020-05-17 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100797083 |
| 230001717 | 230009192 | 1.7 | 63.5 | Palliative (P) | 2019-11-03 | 2019-11-08 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101413067 |
| 230001720 | 230009193 | null | null | null | null | 2022-01-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100401581 |
| 230001723 | 230009194 | 1.54 | 54.1 | null | null | 2021-12-13 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101704693 |